Article
Audiometric abnormalities in children with Gaucher disease type 3.
Neuropediatrics - 1 Jun 2001
Bamiou D E, Campbell P, Liasis A, Page J, Sirimanna T, Boyd S, Vellodi A, Harris C
Abstract excerpt
Exogenous enzyme replacement therapy achieves satisfactory biomedical correction in Gaucher type 1 disease and may halt or reverse neurological progression in type 3, while it does not appear to influence the outcome in type 2. In view of the therapeutic possibilities, early detection and monitoring of type 3 Gaucher disease, as well as evaluation of the effectiveness of enzyme therapy on neuronopathic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
